The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-analysis
Abstract
IMPORTANCE: Thrombolytic therapy may be beneficial in the treatment of some patients with pulmonary embolism. To date, no analysis has had adequate statistical power to determine whether thrombolytic therapy is associated with improved survival, compared with conventional anticoagulation. OBJECTIVE: To determine mortality benefits and bleeding risks associated with thrombolytic therapy compared with anticoagulation in acute pulmonary embolism, including the subset of hemodynamically stable patients with right ventricular dysfunction (intermediate-risk pulmonary embolism). DATA SOURCES: PubMed, the Cochrane Library, EMBASE, EBSCO, Web of Science, and CINAHL databases from inception through April 10, 2014. STUDY SELECTION: Eligible studies were randomized clinical trials comparing thrombolytic therapy vs anticoagulant therapy in pulmonary embolism patients. Sixteen trials comprising 2115 individuals were identified. Eight trials comprising 1775 patients specified inclusion of patients with intermediate-risk pulmonary embolism. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted trial-level data including number of patients, patient characteristics, duration of follow-up, and outcomes. MAIN OUTCOMES AND MEASURES: The primary outcomes were all-cause mortality and major bleeding. Secondary outcomes were risk of recurrent embolism and intracranial hemorrhage (ICH). Peto odds ratio (OR) estimates and associated 95% CIs were calculated using a fixed-effects model. RESULTS: Use of thrombolytics was associated with lower all-cause mortality (OR, 0.53; 95% CI, 0.32-0.88; 2.17% [23/1061] vs 3.89% [41/1054] with anticoagulants; number needed to treat [NNT] = 59) and greater risks of major bleeding (OR, 2.73; 95% CI, 1.91-3.91; 9.24% [98/1061] vs 3.42% [36/1054]; number needed to harm [NNH] = 18) and ICH (OR, 4.63; 95% CI, 1.78-12.04; 1.46% [15/1024] vs 0.19% [2/1019]; NNH = 78). Major bleeding was not significantly increased in patients 65 years and younger (OR, 1.25; 95% CI, 0.50-3.14). Thrombolysis was associated with a lower risk of recurrent pulmonary embolism (OR, 0.40; 95% CI, 0.22-0.74; 1.17% [12/1024] vs 3.04% [31/1019]; NNT = 54). In intermediate-risk pulmonary embolism trials, thrombolysis was associated with lower mortality (OR, 0.48; 95% CI, 0.25-0.92) and more major bleeding events (OR, 3.19; 95% CI, 2.07-4.92). CONCLUSIONS AND RELEVANCE: Among patients with pulmonary embolism, including those who were hemodynamically stable with right ventricular dysfunction, thrombolytic therapy was associated with lower rates of all-cause mortality and increased risks of major bleeding and ICH. However, findings may not apply to patients with pulmonary embolism who are hemodynamically stable without right ventricular dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Büller (2012) · doi:10.1056/nejmoa1113572 · Cited by 2,353
Jaff, M. R., McMurtry, M. S., Archer, S. L., Cushman, M., Goldenberg, N., Goldhaber, S. Z., Jenkins, J. S., Kline, J. A., Michaels, A. D., Thistlethwaite, P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214914f · Cited by 2,229
Self-citationTrial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism
Meyer, G., Vicaut, E., Danays, T., Agnelli, G., Becattini, C., Beyer-Westendorf, J., Bluhmki, E., Bouvaist, H., Brenner, B., Couturaud, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1302097 · Cited by 1,706
Kucher, N., Boekstegers, P., Müller, O. J., Kupatt, C., Beyer-Westendorf, J., Heitzer, T., Tebbe, U., Horstkotte, J., Müller, R., Blessing, E., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005544 · Cited by 1,151
Brok, J., Thorlund, K., Gluud, C., & Wetterslev, J. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.10.007 · Cited by 1,113
Beckman, M. G., Hooper, W. C., Critchley, S. E., & Ortel, T. L. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.12.017 · Cited by 1,055
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
Konstantinides, S., Geibel, A., Heusel, G., Heinrich, F., & Kasper, W. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021274 · Cited by 997
Estimating required information size by quantifying diversity in random-effects model meta-analyses
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-86 · Cited by 938
Goldhaber, S. Z., Come, P. C., Lee, R. T., Braunwald, E., Parker, J. A., Haire, W. D., Feldstein, M. L., Miller, M., Toltzis, R., Smith, J. L., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)90274-k · Cited by 849
Prognostic Value of Troponins in Acute Pulmonary Embolism: A Meta-Analysis
Becattini, C., Vedovati, M. C., & Agnelli, G. (2007) · Circulation · doi:10.1161/circulationaha.106.680421 · Cited by 752
Wan, S., Quinlan, D. J., Agnelli, G., & Eikelboom, J. W. (2004) · Circulation · doi:10.1161/01.cir.0000137826.09715.9c · Cited by 616
Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial)
Sharifi, M., Bay, C., Skrocki, L., Rahimi, F., & Mehdipour, M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.027 · Cited by 582
Sanchez, O., Trinquart, L., Colombet, I., Durieux, P., Huisman, M. V., Chatellier, G., & Meyer, G. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn208 · Cited by 552
Ruíz-Giménez, N., Suárez, C., González, R., Nieto, J., Todolí, J., Samperiz, Á., Monreal, M., & and the RIETE Investigators (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-03-0193 · Cited by 516
Death and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages
Fang, M. C., Go, A. S., Chang, Y., Hylek, E. M., Henault, L. E., Jensvold, N. G., & Singer, D. E. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.07.034 · Cited by 510
Jerjes-Sanchez, C., Ramírez-Rivera, A., de Lourdes García, M., Arriaga-Nava, R., Valencia, S., Rosado-Buzzo, A., Pierzo, J. A., & Rosas, E. (1995) · Journal of Thrombosis and Thrombolysis · doi:10.1007/bf01062714 · Cited by 485
HEPARIN PLUS ALTEPLASE COMPARED WITH HEPARIN ALONE IN PATIENTS WITH SUBMASSIVE PULMONARY EMBOLISM
Onstantinides, S. T. K., Eibel, A. N. G., Eusel, G. E. H., & Einrich, F. R. H. (2002) · Cited by 431
Dalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90002-5 · Cited by 379
Levine, M., Hirsh, J., Weitz, J., Cruickshank, M., Neemeh, J., Turpie, A. G., & Gent, M. (1990) · Chest · doi:10.1378/chest.98.6.1473 · Cited by 308
Thrombolytic Therapy in Unstable Patients with Acute Pulmonary Embolism: Saves Lives but Underused
Stein, P. D., & Matta, F. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.015 · Cited by 293
Kline, J. A., Nordenholz, K. E., Courtney, D. M., Kabrhel, C., Jones, A. E., Rondina, M. T., Diercks, D. B., Klinger, J. R., & Hernandez, J. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12521 · Cited by 291
Tibbutt, D. A., Davies, J. A., Anderson, J. A., Fletcher, E. W. L., Hamill, J., Holt, J. M., Thomas, M. L., Lee, G. D. J., Miller, G. A. H., Sharp, A. A., et al. (1974) · BMJ · doi:10.1136/bmj.1.5904.343 · Cited by 278
Sequential methods for random‐effects meta‐analysis
Higgins, J. P. T., Whitehead, A., & Simmonds, M. (2011) · Statistics in Medicine · doi:10.1002/sim.4088 · Cited by 258
Ly, B., Arnesen, H., Eie, H., & Hol, R. (1978) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1978.tb14909.x · Cited by 223
Becattini, C., Agnelli, G., Salvi, A., Grifoni, S., Pancaldi, L. G., Enea, I., Balsemin, F., Campanini, M., Ghirarduzzi, A., & Casazza, F. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.09.017 · Cited by 218
Tissue Plasminogen Activator for the Treatment of Acute Pulmonary Embolism
(1990) · Chest · doi:10.1378/chest.97.3.528 · Cited by 189
Thrombolytic therapy of pulmonary embolism
Thabut, G., Thabut, D., Myers, R. P., Bernard-Chabert, B., Marrash-Chahla, R., Mal, H., & Fournier, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02381-1 · Cited by 176
Thrombolytic therapy for pulmonary embolism
Dong, B. R., Hao, Q., Yue, J., Wu, T., & Liu, G. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004437.pub3 · Cited by 174
Fasullo, S., Scalzo, S., Maringhini, G., Ganci, F., Cannizzaro, S., Terrazzino, G., Pasquale, P. D., Basile, I., Parrinello, G., Paterna, S., et al. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181f1fc3e · Cited by 153
Marini, C. E., Ricco, G. D., Rossi, G., Rindi, M., Palla, R., & Giuntini, C. (2009) · Respiration · doi:10.1159/000195517 · Cited by 112
O’Mara, C. S. (1991) · Journal of Vascular Surgery · doi:10.1016/0741-5214(91)90067-5 · Cited by 107
Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study
(1970) · JAMA · doi:10.1001/jama.214.12.2163 · Cited by 107
Meneveau, N. F., Bassand, J., Schiele, F., Bouras, Y., Anguenot, T., Bernard, Y. F., & Schultz, R. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90418-z · Cited by 35
Accelerated Thrombolysis for Pulmonary Embolism: Will Clinical Benefit Be ULTIMAtely Realized?
Weinberg, I., & Jaff, M. R. (2013) · Circulation · doi:10.1161/circulationaha.113.007132 · Cited by 22
Self-citation
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
Self-citationKonstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
Self-citation
Metadata
- Authors
- Chatterjee, S., Chakraborty, A., Weinberg, I., Kadakia, M., Wilensky, R. L., Sardar, P., Kumbhani, D. J., Mukherjee, D., Jaff, M. R., & Giri, J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-06-18
- Volume
- 311
- Issue
- 23
- Pages
- 2414
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2129593751
- Cited by
- 818
- References
- 41
- FWCI
- 47.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.